Tempus AI (NASDAQ:TEM) PT Raised to $57.00

Tempus AI (NASDAQ:TEM) had its target price raised by research analysts at Loop Capital from $48.00 to $57.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Loop Capital’s price objective suggests a potential upside of 16.21% from the stock’s previous close.

Several other brokerages also recently commented on TEM. Stifel Nicolaus started coverage on Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $45.00 price objective on the stock. Morgan Stanley began coverage on Tempus AI in a research report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective for the company. Piper Sandler assumed coverage on shares of Tempus AI in a report on Monday, August 12th. They set a “neutral” rating and a $40.00 target price on the stock. William Blair assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued an “outperform” rating for the company. Finally, Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and raised their price objective for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $48.67.

Tempus AI Price Performance

NASDAQ:TEM opened at $49.05 on Tuesday. The company has a current ratio of 3.70, a quick ratio of 3.52 and a debt-to-equity ratio of 4.50. Tempus AI has a 1-year low of $22.89 and a 1-year high of $77.00. The firm has a 50-day moving average of $51.79.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The company had revenue of $165.97 million for the quarter, compared to analyst estimates of $159.10 million. Analysts predict that Tempus AI will post -6.51 earnings per share for the current year.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Davidson Kempner Capital Management LP acquired a new stake in Tempus AI in the second quarter valued at $2,271,000. NEA Management Company LLC bought a new stake in shares of Tempus AI in the 2nd quarter valued at about $160,048,000. Exchange Traded Concepts LLC acquired a new stake in Tempus AI in the 3rd quarter valued at about $3,458,000. Sculptor Capital LP bought a new position in Tempus AI during the second quarter worth about $5,085,000. Finally, Novo Holdings A S bought a new stake in Tempus AI in the second quarter valued at approximately $142,605,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.